Local view for "http://purl.org/linkedpolitics/eu/plenary/2009-03-23-Speech-1-131"
| Predicate | Value (sorted: default) |
|---|---|
| rdf:type | |
| dcterms:Date | |
| dcterms:Is Part Of | |
| dcterms:Language | |
| lpv:document identification number |
"en.20090323.16.1-131"2
|
| lpv:hasSubsequent | |
| lpv:speaker | |
| lpv:translated text |
"Mr President, I should like to thank the speakers for their constructive observations and to say that the evaluation of active substances will in fact ultimately require more time than was initially and optimistically foreseen. In 2000, when the legislation was passed, the evaluation programmes did not start immediately; approximately four years were spent on various preparatory procedures and the evaluation procedures which the national competent authorities are indubitably using only started in 2004. Although very notable and important work has been carried out to date, it will not be possible for many of the active substances to have passed through evaluation by May.
Given that the directive stipulates that biocidal products which contain active substances not included in Annex 1 or 1Α to the directive must be withdrawn from the market by no later than 14 May 2010, it was judged necessary to extend the deadline for completion of the evaluation procedure; otherwise, if we withdraw some of these substances because they have not passed through the evaluation procedure, then both health and the environment in the European Union may be jeopardised and, indubitably, trade will also be obstructed.
On the matter referred to by Mrs Klass, I should like to say that this matter concerns the protection of data submitted for the evaluation of active substances. This applies more specifically to cases in which companies which were not involved in efforts to produce the said data, ‘free riders’, can nonetheless keep their products on the market until expiry of the transitional period.
The Commission is in the final stage of processing the proposal for a substantive revision of the Biocides Directive and this matter was clearly signalled during the consultations carried out when the said proposal was being formulated and drafted. Many of the comments made by Mr Prodi and others will doubtless be taken into account.
The Commission will address the aforementioned issue within the framework of the substantive review of the directive. A Commission statement on this will be sent to the European Parliament secretariat for insertion in the Minutes of today's sitting.
Similarly, numerous other matters highlighted by Parliament will also be addressed in the said proposal, such as the extension of the scope to goods and materials processed using biocides, improved approval procedures for biocidal products, the introduction of compulsory data exchange during product licensing and during approval of the active substance in accordance with the principles of the REACH regulation and alignment with best practice in other legislative acts, such as that passed recently on plant protection products.
To close, the Commission expresses its satisfaction with the outcome of the negotiations. The Commission is in a position to accept the compromise amendments in full and promises to take account, during the main review of the directive, of the concerns about data protection expressed both by the Council and by Parliament here today.
The Commission notes the issues concerning data protection, data sharing and ‘alleged free riders’ that have been raised during the discussions on the proposal for the extension of certain time periods under the Biocides Directive. The Commission will consider appropriate solutions to the identified problems in the framework of the substantive revision of the Biocides Directive."@en1
|
| lpv:unclassifiedMetadata | |
| lpv:videoURI |
Named graphs describing this resource:
The resource appears as object in 2 triples